FENOFIBRIC ACID
- Strength
- 45 mg/1
- Form
- Capsule, Delayed Release
- Class
- Peroxisome Proliferator Receptor alpha …
Leading Pharma, LLC
Not stocked by us — reference only
Listed by Alembic Pharmaceuticals Inc.
| Dosage form | Capsule, Delayed Release |
|---|---|
| Route | Oral |
| Drug class | Peroxisome Proliferator Receptor alpha Agonist |
| Approval route | ANDA — approved generic |
| NDC code | 62332-245 |
| FDA application | ANDA208705 |
| RxNorm concept | 828373 |
| Package sizes listed | 3 |
| Marketed since | May 2017 |
Same active ingredient, different manufacturer, strength or form. Products matching on both ingredient and strength are usually interchangeable — but confirm before switching, especially with modified-release forms.
Leading Pharma, LLC
Not stocked by us — reference only
Aurobindo Pharma Limited
Not stocked by us — reference only
Amneal Pharmaceuticals of New York LLC
Not stocked by us — reference only
Alembic Pharmaceuticals Limited
Not stocked by us — reference only
Alembic Pharmaceuticals Inc.
Not stocked by us — reference only
Leading Pharma, LLC
Not stocked by us — reference only
Aurobindo Pharma Limited
Not stocked by us — reference only
Amneal Pharmaceuticals of New York LLC
Not stocked by us — reference only
Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.
Please don't share card details in chat.